Annual Retained Earnings
-$139.21 M
-$10.83 M-8.43%
December 1, 2023
Summary
- As of February 7, 2025, PHIO annual retained earnings is -$139.21 million, with the most recent change of -$10.83 million (-8.43%) on December 1, 2023.
- During the last 3 years, PHIO annual retained earnings has fallen by -$35.59 million (-34.35%).
- PHIO annual retained earnings is now -3154.76% below its all-time high of -$4.28 million, reached on December 31, 2011.
Performance
PHIO Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$144.73 M
-$1.52 M-1.06%
September 1, 2024
Summary
- As of February 7, 2025, PHIO quarterly retained earnings is -$144.73 million, with the most recent change of -$1.52 million (-1.06%) on September 1, 2024.
- Over the past year, PHIO quarterly retained earnings has dropped by -$7.42 million (-5.40%).
- PHIO quarterly retained earnings is now -3283.91% below its all-time high of -$4.28 million, reached on December 31, 2011.
Performance
PHIO Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
PHIO Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -8.4% | -5.4% |
| 3 y3 years | -34.4% | -5.4% |
| 5 y5 years | -62.0% | -5.4% |
PHIO Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -19.1% | at low | -23.8% | at low |
| 5 y | 5-year | -46.8% | at low | -52.6% | at low |
| alltime | all time | -3154.8% | at low | -3283.9% | at low |
Phio Pharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$144.73 M(+1.1%) |
| Jun 2024 | - | -$143.21 M(+1.3%) |
| Mar 2024 | - | -$141.36 M(+1.5%) |
| Dec 2023 | -$139.21 M(+8.4%) | -$139.21 M(+1.4%) |
| Sep 2023 | - | -$137.31 M(+2.1%) |
| Jun 2023 | - | -$134.53 M(+1.9%) |
| Mar 2023 | - | -$131.98 M(+2.8%) |
| Dec 2022 | -$128.38 M(+9.8%) | -$128.38 M(+2.2%) |
| Sep 2022 | - | -$125.65 M(+2.9%) |
| Jun 2022 | - | -$122.07 M(+2.1%) |
| Mar 2022 | - | -$119.54 M(+2.3%) |
| Dec 2021 | -$116.90 M(+12.8%) | -$116.90 M(+3.0%) |
| Sep 2021 | - | -$113.45 M(+3.4%) |
| Jun 2021 | - | -$109.71 M(+2.5%) |
| Mar 2021 | - | -$107.02 M(+3.3%) |
| Dec 2020 | -$103.61 M(+9.3%) | -$103.61 M(+2.4%) |
| Sep 2020 | - | -$101.15 M(+2.3%) |
| Jun 2020 | - | -$98.84 M(+1.7%) |
| Mar 2020 | - | -$97.17 M(+2.5%) |
| Dec 2019 | -$94.82 M(+10.4%) | -$94.82 M(+2.9%) |
| Sep 2019 | - | -$92.16 M(+2.3%) |
| Jun 2019 | - | -$90.06 M(+2.3%) |
| Mar 2019 | - | -$88.03 M(+2.5%) |
| Dec 2018 | -$85.91 M | -$85.91 M(+2.1%) |
| Sep 2018 | - | -$84.18 M(+1.8%) |
| Jun 2018 | - | -$82.69 M(+2.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | -$80.79 M(+2.9%) |
| Dec 2017 | -$78.55 M(+18.8%) | -$78.55 M(+2.6%) |
| Sep 2017 | - | -$76.55 M(+3.3%) |
| Jun 2017 | - | -$74.07 M(+3.5%) |
| Mar 2017 | - | -$71.56 M(+8.3%) |
| Dec 2016 | -$66.10 M(+15.7%) | -$66.10 M(+3.7%) |
| Sep 2016 | - | -$63.76 M(+3.6%) |
| Jun 2016 | - | -$61.55 M(+3.7%) |
| Mar 2016 | - | -$59.34 M(+3.9%) |
| Dec 2015 | -$57.10 M(+21.8%) | -$57.10 M(+4.8%) |
| Sep 2015 | - | -$54.49 M(+4.8%) |
| Jun 2015 | - | -$51.99 M(+4.3%) |
| Mar 2015 | - | -$49.83 M(+6.3%) |
| Dec 2014 | -$46.88 M(+23.1%) | -$46.88 M(+5.2%) |
| Sep 2014 | - | -$44.58 M(+5.2%) |
| Jun 2014 | - | -$42.37 M(+5.0%) |
| Mar 2014 | - | -$40.37 M(+6.0%) |
| Dec 2013 | -$38.08 M(+122.0%) | -$38.08 M(+7.1%) |
| Sep 2013 | - | -$35.57 M(+6.1%) |
| Jun 2013 | - | -$33.52 M(+6.2%) |
| Mar 2013 | - | -$31.55 M(+83.9%) |
| Dec 2012 | -$17.16 M(+301.1%) | -$17.16 M(+11.1%) |
| Sep 2012 | - | -$15.45 M(+11.9%) |
| Jun 2012 | - | -$13.80 M(+122.5%) |
| Mar 2012 | - | -$6.20 M(+45.0%) |
| Dec 2011 | -$4.28 M | -$4.28 M |
FAQ
- What is Phio Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for Phio Pharmaceuticals?
- What is Phio Pharmaceuticals annual retained earnings year-on-year change?
- What is Phio Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for Phio Pharmaceuticals?
- What is Phio Pharmaceuticals quarterly retained earnings year-on-year change?
What is Phio Pharmaceuticals annual retained earnings?
The current annual retained earnings of PHIO is -$139.21 M
What is the all time high annual retained earnings for Phio Pharmaceuticals?
Phio Pharmaceuticals all-time high annual retained earnings is -$4.28 M
What is Phio Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, PHIO annual retained earnings has changed by -$10.83 M (-8.43%)
What is Phio Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of PHIO is -$144.73 M
What is the all time high quarterly retained earnings for Phio Pharmaceuticals?
Phio Pharmaceuticals all-time high quarterly retained earnings is -$4.28 M
What is Phio Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, PHIO quarterly retained earnings has changed by -$7.42 M (-5.40%)